Growth Metrics

Boston Scientific (BSX) Shareholder's Equity (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.72%
Dec 31, 2025 2.55%
Sep 30, 2025 4,319.64%
Jun 30, 2025 -102.49%
Mar 31, 2025 3.11%
Dec 31, 2024 3.88%
Sep 30, 2024 13,079.87%
Jun 30, 2024 567.65%
Mar 31, 2024 -100.17%
Dec 31, 2023 2.10%
Sep 30, 2023 949.80%
Dec 31, 2022 -104.25%
Mar 31, 2022 990.40%
Dec 31, 2021 -113.67%
Sep 30, 2020 11,780.92%
Jun 30, 2020 107.63%
Mar 31, 2020 -735.93%
Dec 31, 2019 104.32%
Sep 30, 2019 -263.95%
Jun 30, 2019 73.70%
Mar 31, 2019 -137.63%
Dec 31, 2018 69,284.00%
Sep 30, 2018 101.46%
Jun 30, 2018 -109.99%
Mar 31, 2018 107,300.00%
Dec 31, 2017 -99.79%
Sep 30, 2017 4.88%
Jun 30, 2017 2.58%
Mar 31, 2017 510.77%
Dec 31, 2016 -126.49%
Sep 30, 2016 4.21%
Jun 30, 2016 -3.67%
Mar 31, 2016 7,237.50%
Dec 31, 2015 -98.63%
Sep 30, 2015 -2.58%
Jun 30, 2015 1.22%
Mar 31, 2015 -61.08%
Dec 31, 2014 149.26%
Sep 30, 2014 2.40%
Jun 30, 2014 0.15%
Mar 31, 2014 40,737.50%
Dec 31, 2013 -99.76%
Sep 30, 2013 -0.61%
Jun 30, 2013 1.54%
Mar 31, 2013 695.51%
Dec 31, 2012 -115.99%
Sep 30, 2012 -11.65%
Jun 30, 2012 -32.19%
Mar 31, 2012 8,357.97%
Dec 31, 2011 -101.20%
Sep 30, 2011 -0.16%
Jun 30, 2011 1.50%
Mar 31, 2011 8,913.18%
Dec 31, 2010 -101.17%
Sep 30, 2010 1.33%
Jun 30, 2010 1.04%
Mar 31, 2010 25,172.09%
Dec 31, 2009 -100.32%
Sep 30, 2009 -0.87%